Back to News
Market Impact: 0.25
Pfizer's Stock Has Been Crushed—Is Its 6% Dividend Finally Worth Buying?
Source: 247wallst.com
Capital Returns (Dividends / Buybacks)Company Fundamentals
Pfizer’s shareholders are reportedly earning about a 6% dividend yield even as the stock “bleeds value.” The CEO’s pledge to keep the payout intact through what could be the firm’s toughest stretch in years provides some support, but the underlying share-price weakness keeps the overall tone cautious.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
PFE-0.35
More News
- Another BioNTech Cancer Vaccine Just Hit a Major Setback. Is BNTX Stock Still a Buy?
- Warren Buffett's Market Warning Is Hard to Ignore. But I'd Buy These 3 Stocks Anyway.
- Indonesian stocks plunge to six-year low as MSCI downgrade fears mount
- China's CXMT sees shares drop over 6% as investors look past chipmaker's profit turnaround
- Australia’s Cleanaway agrees to $6.5 bln EQT buyout bid; shares surge
- India’s Finance Minister blames easy exits and excess liquidity for equity market's underperformance